Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research.

New Targeted Molecular Agents Tailor Psoriasis Treatment

Psoriasis, one of the most common immune-mediated diseases, currently affects more than 7.5 million adults ages 20 and older in the U.S. The cutaneous condition

March 9, 2024

ASCO 2024: MediLink’s NSCLC and breast cancer ADC shows early safety success – Pharmaceutical Technology

A 3D rendering of an antibody drug conjugate (ADC). YL202/BNT326 is an ADC designed to target HER3 and inhibit topoisomerase 1. Credits: Love Employee/Shutterstock.com MediLink

May 24, 2024

T-cell targeting Candid Therapeutics launches with $370m – Pharmaceutical Technology

Candid plans to develop antibody drugs for inflammatory diseases such as rheumatoid arthritis. Credit: Drazen Zigic via Shutterstock. T cell engager (TCE) startup Candid Therapeutics

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.